As of 2024-09-14, the Relative Valuation of bluebird bio Inc (BLUE) is (21.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.61 USD, the upside of bluebird bio Inc based on Relative Valuation is -3599.5%.
The range of the Relative Valuation is (23.99) - (16.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 50.1x - 61.4x | 57.1x |
| Forward P/E multiples | 26.1x - 34.0x | 31.4x |
| Fair Price | (23.99) - (16.31) | (21.20) |
| Upside | -4060.5% - -2792.0% | -3599.5% |
| Date | P/E |
| 2024-09-13 | -1.26 |
| 2024-09-12 | -1.20 |
| 2024-09-11 | -1.21 |
| 2024-09-10 | -1.19 |
| 2024-09-09 | -1.12 |
| 2024-09-06 | -1.10 |
| 2024-09-05 | -1.19 |
| 2024-09-04 | -1.17 |
| 2024-09-03 | -1.18 |
| 2024-08-30 | -1.17 |
| 2024-08-29 | -1.24 |
| 2024-08-28 | -1.30 |
| 2024-08-27 | -1.32 |
| 2024-08-26 | -1.46 |
| 2024-08-23 | -1.44 |
| 2024-08-22 | -1.41 |
| 2024-08-21 | -1.50 |
| 2024-08-20 | -1.38 |
| 2024-08-19 | -1.44 |
| 2024-08-16 | -1.48 |
| 2024-08-15 | -1.47 |
| 2024-08-14 | -1.70 |
| 2024-08-13 | -2.21 |
| 2024-08-12 | -2.05 |
| 2024-08-09 | -2.08 |
| 2024-08-08 | -2.11 |
| 2024-08-07 | -1.97 |
| 2024-08-06 | -2.13 |
| 2024-08-05 | -2.07 |
| 2024-08-02 | -2.32 |
| 2024-08-01 | -2.25 |
| 2024-07-31 | -2.42 |
| 2024-07-30 | -2.36 |
| 2024-07-29 | -2.55 |
| 2024-07-26 | -2.55 |
| 2024-07-25 | -2.50 |
| 2024-07-24 | -2.40 |
| 2024-07-23 | -2.59 |
| 2024-07-22 | -2.38 |
| 2024-07-19 | -2.19 |
| 2024-07-18 | -2.40 |
| 2024-07-17 | -2.55 |
| 2024-07-16 | -2.82 |
| 2024-07-15 | -2.76 |
| 2024-07-12 | -2.55 |
| 2024-07-11 | -2.36 |
| 2024-07-10 | -2.17 |
| 2024-07-09 | -2.09 |
| 2024-07-08 | -1.95 |
| 2024-07-05 | -1.93 |